Published in BMC Musculoskelet Disord on April 11, 2008
Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol (2011) 1.04
Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine. Bioimpacts (2016) 0.78
Unusual Case of an Alcoholic with Liver Injury from Sulfasalazine Use. J Basic Clin Pharm (2016) 0.75
Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver. Toxicol Res (2016) 0.75
[Differential diagnosis of elevated liver transaminases in rheumatic diseases]. Z Rheumatol (2015) 0.75
Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents. Clin Rheumatol (2014) 0.75
Severe adverse cutaneous reactions to drugs. N Engl J Med (1994) 8.47
Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol (1993) 7.63
Drug-related hepatotoxicity. N Engl J Med (2006) 7.49
Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol (2006) 6.91
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg (1996) 5.05
Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis (2005) 4.67
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology (2001) 2.40
Detection, verification, and quantification of adverse drug reactions. BMJ (2004) 2.26
Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology (2003) 2.01
Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum (1999) 1.78
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol (2005) 1.45
Prescription-event monitoring and reporting of adverse drug reactions. Lancet (2001) 1.42
Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency. J Investig Allergol Clin Immunol (2011) 1.34
Accuracy of hepatic adverse drug reaction reporting in one English health region. BMJ (1999) 1.31
A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.27
Sulphasalazine hepatotoxicity: lack of a hypersensitivity response. Ann Rheum Dis (1986) 1.09
Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology (2001) 1.05
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol (2007) 1.03
Liver involvement in the sulfone syndrome. Arch Intern Med (1986) 1.01
N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse events. Biol Pharm Bull (2002) 0.98
Drug reactions to the sulfones. Arch Dermatol (1970) 0.92
Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis. Scand J Rheumatol (1992) 0.87
Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology (1981) 0.83
Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine. Br J Dermatol (2003) 0.81
Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity. J Clin Pharmacol (2002) 0.80
N-acetyltransferase 2 genotyping: an accurate and feasible approach for simultaneous detection of the most common NAT2 alleles. Clin Chem (2004) 0.79
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience. Drug Saf (2002) 0.78
Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. J Invest Dermatol (2003) 0.77
Adverse drug reactions. Lancet (2001) 0.77
Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum (2010) 3.08
Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum (2008) 2.83
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford) (2009) 2.44
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol (2009) 2.22
Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis (2011) 1.96
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis (2012) 1.78
The effect of acupuncture on the symptoms of knee osteoarthritis--an open randomised controlled study. Acupunct Med (2004) 1.73
A pragmatic randomised controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis. BMC Musculoskelet Disord (2007) 1.64
A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis (2011) 1.63
Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis (2010) 1.59
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum (2006) 1.56
Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost (2003) 1.55
Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum (2011) 1.46
Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology (2008) 1.39
Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis (2011) 1.39
A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum (2005) 1.36
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol (2012) 1.35
Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis (2011) 1.34
Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint. PLoS One (2010) 1.31
Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann Rheum Dis (2011) 1.26
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis (2010) 1.25
Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum (2006) 1.20
Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Res Ther (2006) 1.17
Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. J Immunol (2004) 1.17
Annexin-1 modulates T-cell activation and differentiation. Blood (2006) 1.10
Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Res Ther (2008) 1.10
Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol (2009) 1.07
Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint. Arthritis Rheum (2007) 1.04
Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum (2009) 1.02
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome. Ann Rheum Dis (2012) 1.02
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis. Arthritis Rheum (2013) 1.01
The influence of ethnicity on the extent of, and reasons underlying, delay in general practitioner consultation in patients with RA. Rheumatology (Oxford) (2010) 0.99
The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum (2013) 0.97
Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis. Ann Rheum Dis (2009) 0.94
The role of the synovial fibroblast in rheumatoid arthritis pathogenesis. Curr Opin Rheumatol (2015) 0.94
Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer. Swiss Med Wkly (2012) 0.94
Predicting the development of RA in patients with early undifferentiated arthritis. Best Pract Res Clin Rheumatol (2009) 0.92
Symptom complexes at the earliest phases of rheumatoid arthritis: a synthesis of the qualitative literature. Arthritis Care Res (Hoboken) (2013) 0.92
Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Ann Rheum Dis (2010) 0.91
Risk of rheumatoid arthritis development in patients with unclassified arthritis according to the 2010 ACR/EULAR criteria for rheumatoid arthritis. Rheumatology (Oxford) (2013) 0.90
Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression. Arthritis Res Ther (2010) 0.90
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care Res (Hoboken) (2010) 0.90
New pathogenic insights into rheumatoid arthritis. Curr Opin Rheumatol (2015) 0.89
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells. Arthritis Rheum (2012) 0.89
Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation. Arthritis Res Ther (2010) 0.88
An observational study of endothelial function in early arthritis. Eur J Clin Invest (2011) 0.88
Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis. Arthritis Res Ther (2012) 0.86
The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue. Arthritis Rheum (2011) 0.86
Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells. Arthritis Rheum (2008) 0.86
Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans. PLoS One (2013) 0.86
A study of parenteral use of methotrexate in rheumatic conditions. J Clin Nurs (2002) 0.86
Stromal cells differentially regulate neutrophil and lymphocyte recruitment through the endothelium. Immunology (2010) 0.86
The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis. BMC Musculoskelet Disord (2010) 0.85
Latest advances in connective tissue disorders. Ther Adv Musculoskelet Dis (2013) 0.85
Sjögren's syndrome. Clin Med (2007) 0.85
Endothelial cells, fibroblasts and vasculitis. Rheumatology (Oxford) (2005) 0.85
Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome. Scand J Immunol (2013) 0.85
Self-management strategies used during flares of rheumatoid arthritis in an ethnically diverse population. Musculoskeletal Care (2010) 0.84
General practitioners' perspectives on campaigns to promote rapid help-seeking behaviour at the onset of rheumatoid arthritis. Scand J Prim Health Care (2014) 0.83
The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis. Front Biosci (2008) 0.83
The role of leukocyte-stromal interactions in chronic inflammatory joint disease. Joint Bone Spine (2005) 0.82
The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12. J Rheumatol (2015) 0.82
The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome. BMC Musculoskelet Disord (2014) 0.80
Differential regulation of nuclear and mitochondrial Bcl-2 in T cell apoptosis. Apoptosis (2008) 0.79
Positron emission tomography aids diagnosis of relapsing polychondritis. BMJ Case Rep (2014) 0.79
Exploring the cultural validity of rheumatology outcomes. Br J Nurs (2012) 0.79
Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation. Arthritis Res Ther (2013) 0.79
A mixed methods protocol to investigate medication adherence in patients with rheumatoid arthritis of White British and South Asian origin. BMJ Open (2013) 0.78
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience. Drug Saf (2002) 0.78
Glucocorticoid metabolism in rheumatoid arthritis. Ann N Y Acad Sci (2014) 0.78
Patient self-injection of methotrexate for inflammatory arthritis: a study evaluating the introduction of a new type of syringe and exploring patients' sense of empowerment. Musculoskeletal Care (2008) 0.78
Breaking communication barriers for RA patients of South Asian origin: the use of a bilingual educational audio CD and linguistically appropriate peer support and education. Musculoskeletal Care (2010) 0.78
Endogenous glucocorticoids in inflammation: contributions of systemic and local responses. Swiss Med Wkly (2012) 0.77
Breastfeeding practice, oral contraceptive use and risk of rheumatoid arthritis among Chinese women: the Guangzhou Biobank Cohort Study. Rheumatology (Oxford) (2014) 0.76
Experience with a Punjabi, Urdu and Hindi rheumatology telephone helpline. Musculoskeletal Care (2009) 0.76
Benchmarking the nurse consultant role in rheumatology. Nurs Stand (2006) 0.76
Rheumatoid arthritis: what do we mean by early? Rheumatology (Oxford) (2012) 0.76
Endogenous retrovirus ERV-3 is not implicated in rheumatoid arthritis but may provide a biomarker for osteoarthritis. J Rheumatol (2010) 0.76
Targeting stromal cells in chronic inflammation. Discov Med (2007) 0.75